| abstract |
FIELD: medicine.SUBSTANCE: invention relates to medicine and concerns a method for treating patients with chronic kidney disease of stage V at the dialysis stage, consisting in program hemodialysis and drug exposure, including taking drugs belonging to the groups of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers, statins, antiplatelet agents, drugs that affect calcium-phosphorus metabolism, ketoanalogues of essential amino acids, where a high-protein dietary component medicinal effects include an immobilized liquid probiotic “LB-complex-L” with two 50-day courses with an interval between them of 4 months at the rate of 10 ml once a day.EFFECT: invention provides the restoration of the evolutionarily determined structure of the microbiocenosis and the normalization of its function.1 cl, 8 tbl, 6 ex |